Design of Multivalent Inhibitors for Preventing Cellular Uptake

Area of Science:

• Virology
• Biophysics
• Computational Biology

Background:

• Viral entry into host cells is a critical step in infection.
• Inhibiting viral entry is a key strategy for developing antiviral therapies.
• The properties of surface-adsorbed inhibitors that enhance effectiveness beyond simple affinity are not well understood.

Purpose of the Study:

• To investigate the properties of multivalent inhibitors that increase their effectiveness in blocking cellular entry.
• To compare the efficiency of multivalent inhibitors with monovalent inhibitors in preventing viral uptake.
• To explore the role of binding site co-localization and potential side effects like virus aggregation.

Main Methods:

• Computational simulations were employed to model the interaction of inhibitors with viral surface receptors.
• The study compared the number of binding sites required for inhibition by monovalent versus multivalent inhibitors.
• The effect of Janus-like inhibitors on virus aggregation was specifically simulated.

Main Results:

• Multivalent inhibitors demonstrated significantly higher efficiency in preventing cellular entry compared to monovalent inhibitors.
• A single multivalent inhibitor spanning 5-6 binding sites was sufficient to block uptake, versus 1/3 of all receptor sites for monovalent inhibitors.
• The enhanced efficacy of multivalent inhibitors was primarily attributed to the co-localization of inhibited receptor binding sites on the virion surface.
• Janus-like inhibitors were shown not to induce virus aggregation.

Conclusions:

• Multivalent inhibitors represent a more effective strategy for blocking viral cellular entry than monovalent inhibitors.
• The spatial arrangement and co-localization of binding sites are crucial factors driving the superior performance of multivalent inhibitors.
• These findings have implications for designing novel antiviral agents and can be generalized to other cellular uptake processes.